FDA Inspection 1307736 - Paul W. Wallace, MD - March 17, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Paul W. Wallace, MD

Record Details

This FDA Inspection record concerns Paul W. Wallace, MD, with an inspection on March 17, 2026, issued by the Los Angeles District Office, covering human drugs.

Company: Paul W. Wallace, MD
Inspection Date: March 17, 2026
Product Type: Human Drugs
Office: Los Angeles District Office

Open in Dashboard

ID · f6ed70f6-0bc5-4521-9c11-8fcd6786192e

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.